A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy

Kentaro Toyota, Taeko Hashimoto, Daisuke Ogino, Akira Matsunaga, Minoru Ito, Ikuto Masakane, Noriyuki Degawa, Hiroshi Sato, Sayuri Shirai, Kazuo Umetsu, Gen Tamiya, Takao Saito, Kiyoshi Hayasaka

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Lipoprotein glomerulopathy (LPG) is a hereditary disease characterized by lipoprotein thrombi in the glomerulus, hyperlipoproteinemia, and a marked increase in serum apolipoprotein E (APOE). More than 12 APOE mutations have been identified as causes of LPG, and APOE-Sendai (Arg145Pro) mutation was frequently detected in patients from the eastern part of Japan including Yamagata prefecture. Recently, effective therapy with intensive lipid-lowering agents was established, and epidemiologic data are required for early diagnosis. We determined the haplotype structure of APOE-Sendai in 13 patients from 9 unrelated families with LPG, and found that the haplotype of all APOE-Sendai mutations was identical, suggesting that APOE-Sendai mutation is common in Japanese patients probably through a founder effect. We also studied the gene frequency of APOE-Sendai in 2023 control subjects and 418 patients receiving hemodialysis in Yamagata prefecture using the TaqMan method, but did not identify any subjects carrying the mutation, indicating that it is very rare in the general population even in the eastern part of Japan. In addition to APOE mutation, other genetic and/or epigenetic factors are considered to be involved in the pathogenesis of LPG because of its low penetrance. The patients did not have a common haplotype of the counterpart APOE allele, and some patients had the same haplotype of the counterpart APOE allele as the asymptomatic carriers. These results suggest that the counterpart APOE allele is not likely associated with the onset of LPG. Further study is required to clarify the pathogenesis of LPG.

Original languageEnglish
Pages (from-to)254-258
Number of pages5
JournalJournal of Human Genetics
Volume58
Issue number5
DOIs
Publication statusPublished - 2013 May

Keywords

  • APOE
  • APOE-Sendai
  • lipoprotein glomerulopathy

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy'. Together they form a unique fingerprint.

  • Cite this

    Toyota, K., Hashimoto, T., Ogino, D., Matsunaga, A., Ito, M., Masakane, I., Degawa, N., Sato, H., Shirai, S., Umetsu, K., Tamiya, G., Saito, T., & Hayasaka, K. (2013). A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy. Journal of Human Genetics, 58(5), 254-258. https://doi.org/10.1038/jhg.2013.8